Resproly is a comprehensive innovative biopharmaceutical enterprise that specializes in the research and development, production, and sales of inhalation drug and devices. The company‘s goal is to become a leading enterprise in the field of inhalation drug and device R&D and manufacturing，focus on respiratory disease area: Asthma, COPD, IPF and PAH et al.